Life-threatening myositis after one dose of nivolumab in a patient with nonmetastatic completely resected cutaneous melanoma

Saved in:
Bibliographic Details
Published inActa neurologica Belgica Vol. 122; no. 6; pp. 1637 - 1639
Main Authors Rus, Tomaž, Gregorič Kramberger, Milica, Brecl Jakob, Gregor, Leonardis, Lea, Meznaric, Marija
Format Journal Article
LanguageEnglish
Published Cham Springer International Publishing 01.12.2022
Subjects
Biomedical and Life Sciences
Biomedicine
Humans
Letter to the Editor
Medicin och hälsovetenskap
Medicine/Public Health
Melanoma - drug therapy
Melanoma - surgery
Melanoma, Cutaneous Malignant
Myositis - chemically induced
Myositis - diagnostic imaging
Neurology
Neuroradiology
Neurosciences
Nivolumab - adverse effects
Skin Neoplasms - drug therapy
Skin Neoplasms - surgery
Nivolumab-induced myositis
Immune checkpoint inhibitors
Adverse events
Nonmetastatic melanoma
Adjuvant therapy
Online AccessGet full text

Cover

More Information
ISSN:0300-9009
2240-2993
2240-2993
DOI:10.1007/s13760-021-01760-9